BMS, Japan firm collaborate to develop new immunotherapies

Singapore: Japan's Kyowa Hakko Kirin and Bristol-Myers Squibb have entered into a clinical trial collaboration agreement...

July 30, 2015 | Thursday | News
Takeda, Immunogen in a cancer drug deal

Singapore: Immunogen has inked a pact with Japanese drugmaker Takeda pharmaceuticals that gives Takeda exclusive rights ...

March 25, 2015 | Wednesday | News
Suven secures patents in four countries

Singapore: The granted claims of the patent include the class of selective H3 ligands discovered by Suven and are being...

February 21, 2015 | Saturday | News
WHO launches emergency response to drug resistance

Singapore: On World Malaria Day, April 25, the WHO recognized significant accomplishments made in preventing and control...

April 25, 2013 | Thursday | News
Roche study: Obinutuzumab better than Rituxan

Singapore: Roche reported that an independent data monitoring committee has obtained positive results from the phase III...

July 25, 2013 | Thursday | News
Astellas, KEK sign deal for neglected diseases research

Singapore: The High Energy Accelerator Research Organization (KEK) and Japan-based Astellas Pharma have concluded an agr...

September 26, 2012 | Wednesday | News
Alzheimer's research gets a push from Servier

Singapore: Research on treatment of Alzheimer's disease received a fillip with Australian scientists working on it recei...

October 2, 2012 | Tuesday | News
Brisbane biotech secures $14 mn for drug discovery

Singapore: The University of Queensland-based biotechnology company Protagonist Therapeutics has secured $14 million in ...

July 10, 2013 | Wednesday | News
NZ firm migrates to Aus to capitalize on MS drug

Singapore: New Zealand-based biopharmaceutical company Innate Immunotherapeutics is migrating to Australia in a move to ...

September 11, 2013 | Wednesday | News
Dengue incurs annual cost of $950 mn to SE Asia

Philippines: The economic burden churned by mosquito borne disease, dengue, is costing upto $950 million to south east A...

June 20, 2014 | Friday | Analysis
NSC lung cancer drug pipeline is strong: Analyst

Singapore: Non-Small Cell Lung Cancer (NSCLC) treatment pipeline has a diverse selection of 122 first-in-class products ...

November 11, 2014 | Tuesday | Analysis
Are declining Ebola cases a challenge for clinical studies?

Singapore: The steady decline in new ebola cases presents a formidable challenge to current and future clinical trials o...

March 16, 2015 | Monday | Analysis
BMS releases $3.5 mn fund for Hep B&C in India, China

Singapore: Bristol-Myers-Squibb Foundation has released nine new grants totaling to around $3.5 million towards hepatiti...

December 4, 2014 | Thursday | News
AMRI acquires Cedarburg at $41mn

Singapore: AMRI has completed the acquisition of Cedarburg Pharmaceuticals, a contract developer and manufacturer of tec...

April 8, 2014 | Tuesday | News
Latanoprost improves glucose, lipid disorder in diabetes

Singapore: Researchers from Shanghai Institute of Materia Medica, Chinese Academy of Science, have discovered that Latan...

September 9, 2013 | Monday | News
QRxPharma refiles Moxduo NDA with FDA

Singapore: Australia-based QRxPharma has resubmitted its Moxduo new drug application (NDA) after the US Food and Drug Ad...

November 26, 2013 | Tuesday | News
Eli Lilly partners with BioNTech to develop cancer immunotherapies

Singapore: Eli Lilly has partnered with German firm, BioNTech, to discover novel cancer immunotherapies through body's o...

May 12, 2015 | Tuesday | News
Boehringer Ingelheim collaborates with Harvard University

Singapore: Boehringer Ingelheim has established a translational research collaboration with the presidents and fellows o...

July 10, 2012 | Tuesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls